Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 401


US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses.

Gejerman G, Ciccone P, Goldstein M, Lanteri V, Schlecker B, Sanzone J, Esposito M, Rome S, Ciccone M, Margolis E, Simon R, Guo Y, Pentakota SR, Sadhegi-Nejad H.

Investig Clin Urol. 2017 Nov;58(6):423-428. doi: 10.4111/icu.2017.58.6.423. Epub 2017 Nov 2.


Prostate cancer screening: Knowledge, attitudes and practices in a sample of men in Italy. A survey.

Morlando M, Pelullo CP, Di Giuseppe G.

PLoS One. 2017 Oct 12;12(10):e0186332. doi: 10.1371/journal.pone.0186332. eCollection 2017.


Prevalence and survival prognosis of prostate cancer in patients with end-stage renal disease: a retrospective study based on the Korea national database (2003-2010).

Kim SH, Joung JY, Suh YS, Kim YA, Hong JH, Kuark TS, Lee ES, Lee KH.

Oncotarget. 2017 Jul 22;8(38):64250-64262. doi: 10.18632/oncotarget.19453. eCollection 2017 Sep 8.


Determinants of Behavioral Intentions to Screen for Prostate Cancer in Omani Men.

Muliira JK, Al-Saidi HS, Al-Yahyai AN.

Asia Pac J Oncol Nurs. 2017 Oct-Dec;4(4):348-355. doi: 10.4103/apjon.apjon_34_17.


Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer.

Souza MF, Kuasne H, Barros-Filho MC, Cilião HL, Marchi FA, Fuganti PE, Paschoal AR, Rogatto SR, Cólus IMS.

PLoS One. 2017 Sep 14;12(9):e0184094. doi: 10.1371/journal.pone.0184094. eCollection 2017.


Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions.

Driedger SM, Annable G, Brouwers M, Turner D, Maier R.

BMC Cancer. 2017 Sep 13;17(1):647. doi: 10.1186/s12885-017-3596-7.


Low-Risk Prostate Cancer and Tumor Upgrading in the Surgical Specimen: Analysis of Clinical Factors Predicting Tumor Upgrading in a Contemporary Series of Patients Who were Evaluated According to the Modified Gleason Score Grading System.

Porcaro AB, Siracusano S, de Luyk N, Corsi P, Sebben M, Tafuri A, Mattevi D, Bizzotto L, Tamanini I, Cerruto MA, Martignoni G, Brunelli M, Artibani W.

Curr Urol. 2017 Aug;10(3):118-125. doi: 10.1159/000447164. Epub 2017 Jul 30.


An educational intervention to increase awareness reduces unnecessary laboratory testing in an internal medicine resident-run clinic.

Leung E, Song S, Al-Abboud O, Shams S, English J, Naji W, Huang Y, Robison L, Balis F, Kawsar HI.

J Community Hosp Intern Med Perspect. 2017 Jul 13;7(3):168-172. doi: 10.1080/20009666.2017.1335154. eCollection 2017 Jul.


Implications of prostate-specific antigen screening guidelines on clinical practice at a Canadian regional community hospital.

Webster TM, Lau E, Newell KJ.

Can Urol Assoc J. 2017 Aug;11(8):283-286. doi: 10.5489/cuaj.4140. No abstract available.


Most of patients with localized prostate cancer will be treated in the future? | Opinion: No.

Schulman AA, Polascik TJ.

Int Braz J Urol. 2017 Jul-Aug;43(4):584-587. doi: 10.1590/S1677-5538.IBJU.2017.04.03. No abstract available.


Development and clinical testing of individual immunoassays for the quantification of serum glycoproteins to diagnose prostate cancer.

Endt K, Goepfert J, Omlin A, Athanasiou A, Tennstedt P, Guenther A, Rainisio M, Engeler DS, Steuber T, Gillessen S, Joos T, Schiess R.

PLoS One. 2017 Aug 2;12(8):e0181557. doi: 10.1371/journal.pone.0181557. eCollection 2017.


Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening.

Kotwal AA, Schonberg MA.

Cancer J. 2017 Jul/Aug;23(4):246-253. doi: 10.1097/PPO.0000000000000274.


Role of mpMRI of the prostate in screening for prostate cancer.

Wallis CJD, Haider MA, Nam RK.

Transl Androl Urol. 2017 Jun;6(3):464-471. doi: 10.21037/tau.2017.04.31. Review.


Cost consideration in utilization of multiparametric magnetic resonance imaging in prostate cancer.

Hutchinson R, Lotan Y.

Transl Androl Urol. 2017 Jun;6(3):345-354. doi: 10.21037/tau.2017.01.13. Review.


Words do matter: a systematic review on how different terminology for the same condition influences management preferences.

Nickel B, Barratt A, Copp T, Moynihan R, McCaffery K.

BMJ Open. 2017 Jul 10;7(7):e014129. doi: 10.1136/bmjopen-2016-014129.


Letter to the Editor.

McKenzie B.

J Vet Intern Med. 2017 Sep;31(5):1369. doi: 10.1111/jvim.14786. Epub 2017 Jul 4. No abstract available.

Supplemental Content

Support Center